ARTICLE | Clinical News
Cancer vaccine: Phase I
October 28, 2002 8:00 AM UTC
Final results from a previously reported Australian Phase I trial in 10 patients showed that all patients given the vaccine had tumor-specific immune responses. PRR's Cancer Vac Ltd. subsidiary said ...